Biomet, a major manufacturer of artificial hips and knees, said on December 18th that it had agreed to a $10.9 billion buyout offer from a private investment consortium.

The bid came from affiliates of the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Company and the Texas Pacific Group. Biomet said the private investment group was also expected to include Dane A. Miller, a co-founder of Biomet in 1977 and its longtime chief executive until he resigned in April, citing disagreements with the board.

Recent rumors had suggested that Biomet would merge with Smith & Nephew, a British orthopedics company. Smith & Nephew said in November that the two companies had been in talks but it has since indicated that those discussions had ended. 

View entire article from The New York Times

(Registration required) 

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!